Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CERE | CORT | STVN | ||
| Company | Cerevel Therapeutics Hldg Inc | Corcept Therapeutics | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 44.99 | 90.30 | 18.60 | ||
| High | 44.99 | 90.30 | 19.02 | ||
| Low | 44.96 | 86.82 | 18.57 | ||
| Latest | 44.96 | 90.21 | 19.00 | ||
| Change | +0.33 | +1.73 | +0.66 | ||
| % Change | +0.74% | +1.96% | +3.60% | ||
| Volume | 15,096,300 | 772,000 | 337,500 | ||
| 20-Day Average Volume | 2,839,210 | 1,005,375 | 393,825 | ||
| Previous Close | 44.63 | 88.48 | 18.34 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.53 | 81.89 | 17.62 | ||
| 20-Day Raw Stochastic | 99.49% | 95.78% | 78.00% | ||
| 20-Day Relative Strength | 68.05 | 79.61 | 59.93 | ||
| Weighted Alpha | +49.03 | +152.93 | -17.35 | ||
| Today's Opinion | 72% Buy | 88% Buy | 24% Buy | ||
| Previous Opinion | 72% Buy | 88% Buy | 24% Buy | ||
| Last Month's Opinion | 8% Buy | 40% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 07/24/24 | +6.44% since 06/25/26 | +3.32% since 06/25/26 | ||
| Low | 43.75 on 07/25/24 | 82.31 on 06/26/26 | 17.23 on 06/29/26 | ||
| High | 44.99 on 07/31/24 | 91.00 on 07/01/26 | 19.02 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +9.95% since 06/28/24 | +26.70% since 06/02/26 | +1.12% since 06/02/26 | ||
| Low | 39.16 on 07/03/24 | 70.07 on 06/03/26 | 16.27 on 06/16/26 | ||
| High | 44.99 on 07/31/24 | 91.00 on 07/01/26 | 19.77 on 06/05/26 | ||
| 3-Month | |||||
| %Chg | +5.27% since 04/30/24 | +112.31% since 04/02/26 | +38.38% since 04/02/26 | ||
| Low | 38.50 on 06/25/24 | 40.36 on 04/07/26 | 13.39 on 04/10/26 | ||
| High | 44.99 on 07/31/24 | 91.00 on 07/01/26 | 19.77 on 06/05/26 | ||
| 6-Month | |||||
| %Chg | +6.82% since 01/30/24 | +136.15% since 01/02/26 | -7.68% since 01/02/26 | ||
| Low | 38.50 on 06/25/24 | 28.66 on 02/19/26 | 12.89 on 03/27/26 | ||
| High | 44.99 on 07/31/24 | 91.00 on 07/01/26 | 22.00 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,191,488 | 9,684,223 | 5,754,017 | ||
| Shares Outstanding, K | 182,195 | 107,352 | 302,843 | ||
| Annual Sales | 0 | 761,410,000 | 1,342,160,000 | ||
| Annual Net Income | -432,840,000 | 99,650,000 | 158,210,000 | ||
| Last Quarter Sales | 0 | 164,900,000 | 320,190,000 | ||
| Last Quarter Net Income | -131,910,000 | -31,760,000 | 32,810,000 | ||
| 60-Month Beta | 1.40 | 0.47 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/24 | -0.30 on 04/30/26 | 0.13 on 05/07/26 | ||
| Earnings Date | 08/07/24 | 07/30/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 252.80 | 29.58 | ||